Axicabtagene Ciloleucel market size is expected to grow from US$ 1244 million in 2021 to US$ 6854 million by 2028, at a CAGR of 24% during the forecast period 2022-2028. It used for the treatment of adult patients with recurrent or refractory large non-cell lymphoma after two or more systemic treatments,including diffuse large non-cell lymphoma(non-cell […]
